DH - Definitive Healthcare GAAP EPS of -$0.05 beats by $0.03 revenue of $54.5M beats by $0.87M

August, 04 2022 04:41 PM Definitive Healthcare Corp.

Definitive Healthcare press release ( NASDAQ: DH ): Q2 GAAP EPS of -$0.05 beats by $0.03 .
Revenue of $54.5M (+36.9% Y/Y) beats by $0.87M .
Based on information as of August 4, 2022, the Company is issuing the following financial guidance. Third Quarter 2022:
Revenue is expected to be in the range of $56.0 – $57.0 million, a 31% increase year over year.
Adjusted Operating Income is expected to be in the range of $14.5– $15.5 million.
Adjusted EBITDA is expected to be in the range of $15.5– $16.5 million.
Adjusted Net Income is expected to be $6.5 – $7.5 million.
Adjusted Net Income Per Diluted Share is expected to be $0.03 – $0.05 on approximately 155.4 million weighted-average shares outstanding.
Revenue is expected to be in the range of $220.5 – $224.5 million, an increase of 34% from prior year at the midpoint for the full year.
Adjusted Operating Income is expected to be in the range of $58.5 – $61.5 million.
Adjusted EBITDA is expected to be in the range of $63.0 – $66.0 million.
Adjusted Net Income is expected to be $29.0 – $32.0 million.
Adjusted Net Income Per Diluted Share is expected to be $0.18– $0.21 on approximately 155.1 million weighted-average shares outstanding.

For further details see: